AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 173 filers reported holding AXSOME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $956 | -55.0% | 13,686 | -53.7% | 0.10% | -41.4% |
| Q2 2023 | $2,126 | +468.4% | 29,579 | +387.2% | 0.16% | +305.0% |
| Q1 2023 | $374 | -99.9% | 6,071 | -35.9% | 0.04% | +2.6% |
| Q3 2022 | $422,000 | +31.9% | 9,466 | +13.3% | 0.04% | +44.4% |
| Q2 2022 | $320,000 | -52.2% | 8,355 | -58.8% | 0.03% | -54.2% |
| Q3 2021 | $669,000 | +99.1% | 20,292 | +241.6% | 0.06% | +145.8% |
| Q1 2021 | $336,000 | -61.7% | 5,940 | -51.8% | 0.02% | -84.1% |
| Q3 2020 | $878,000 | +78.5% | 12,320 | +105.9% | 0.15% | +164.9% |
| Q2 2020 | $492,000 | +720.0% | 5,984 | -67.8% | 0.06% | +1800.0% |
| Q2 2018 | $60,000 | – | 18,609 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |